Vivimed Labs Limited Bombay S.E.

VIVIMEDLAB

INE526G01021

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 06:14:08 2023-07-31 am EDT			5-day change	1st Jan Change
4.9 ^INR	-3.92%		-.--%	-.--%

May. 04	Vivimed Labs Limited Announces Change in Corporate Office Address	CI
Feb. 26	Vivimed Labs CFO Resigns	MT

Vivimed Labs Limited Announces Resignation of Srinivas Chidambaram from the Board of Directors

January 11, 2016 at 05:51 am EST

Vivimed Labs Ltd. has informed that the Board of Directors of the company at its meeting held on January 11, 2016, have approved the resignation of Mr. Srinivas Chidambaram from the Board of Directors of the company and Consequently reconstituted the Audit Committee.

Latest news about Vivimed Labs Limited

Vivimed Labs Limited Announces Change in Corporate Office Address	May. 04	CI
Vivimed Labs CFO Resigns	Feb. 25	MT
Vivimed Labs Limited Announces Resignation of Ramakanta Tripathy as Chief Financial Officer	Feb. 24	CI
Vivimed Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Vivimed Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
Vivimed Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Vivimed Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-30	CI
Vivimed Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
Vivimed Labs Limited Announces Change in Corporate Office Address	23-03-17	CI
Vivimed Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Vivimed Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI

Chart Vivimed Labs Limited

Duration

Period

More charts

Company Profile

Vivimed Labs Limited is an India-based company, which is primarily engaged in the business of active pharmaceuticals ingredients, contract development and manufacturing operations finished dosage formulation, specialty chemicals and retail branded formulation manufacturing. The Company has two segments: Speciality Chemicals Business and Pharma Business. It supplies niche molecules and formulations for healthcare, pharmaceuticals and specialty chemical consumers in nearly 50 countries. Its active ingredients are used in home and personal care products, such as hair, skin, oral care and anti-microbial preservatives. It also offers industrial care products, such as photo chromic dyes and imaging chemicals. Its presence in active pharmaceutical ingredients, finished dosage formulation (FDF) and retail branded formulation manufacturing, caters to the inner health of people. Within the FDF business, it provides contract manufacturing services and the manufacture of branded formulations.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+55.35%	848B
NOVO NORDISK A/S	+31.64%	627B
JOHNSON & JOHNSON	-0.10%	363B
MERCK & CO., INC.	+15.47%	318B
ABBVIE INC.	+13.10%	299B
ASTRAZENECA PLC	+15.51%	243B
NOVARTIS AG	+16.72%	225B
AMGEN INC.	+16.54%	179B
PFIZER, INC.	+4.31%	167B